preclamol has been researched along with vasoactive intestinal peptide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magistretti, PJ; Ofori, S; Schorderet, M | 1 |
| Goiny, M; Uvnäs-Moberg, K | 1 |
| Ekman, A; Eriksson, E; Hellstrand, M; Nilsson, CL | 1 |
3 other study(ies) available for preclamol and vasoactive intestinal peptide
| Article | Year |
|---|---|
Investigation of dopamine content, synthesis, and release in the rabbit retina in vitro: II. Effects of high potassium, adenylate cyclase activators, and N-n-propyl-3-(3-hydroxyphenyl) piperidine.
Topics: 2-Chloroadenosine; Adenosine; Adenylyl Cyclases; Animals; Calcium; Colforsin; Dopamine; Enzyme Activation; Female; Male; Piperidines; Potassium; Rabbits; Retina; Tyrosine 3-Monooxygenase; Vasoactive Intestinal Peptide | 1986 |
Effects of dopaminomimetics on the secretion of VIP-like immunoreactivity in conscious dogs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Apomorphine; Benzazepines; Dogs; Ergolines; Nitroglycerin; Pergolide; Piperidines; Prazosin; Receptors, Dopamine; Somatostatin; Vasoactive Intestinal Peptide | 1986 |
The intrinsic activity of (-)-3-PPP vis-à-vis prolactin-suppressing dopamine D2 receptors in transfected GH4C1 cells is dependent on which secretagogue that is used to provoke prolactin release.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Cell Line; Dopamine; Dopamine Agonists; Humans; Piperidines; Potassium; Prolactin; Receptors, Dopamine D2; Tetraethylammonium; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide | 1998 |